Mixed Treatment Comparisons, Network Meta-Analysis

Read More

 

Health Economics Modeling and Pricing (HAS CEESP, CEPS)

Read More

 

Statistical Analysis of Real Life Data

Read More

 

Re-use of Open Data and Data science: Industry, Institutions

Read More

 

Welcome

Statésia is a research and consulting firm specialized in comparative effectiveness research and medico-economic analysis of health products, technologies and strategies (for HAS CT, HAS CEESP, CEPS submissions).

Our competitive advantage is founded on a strong collaborative action with the Applied Mathematics Research team of the University of Maine (EA 3263), for performing suitable modeling techniques.

This decision analysis is founded on:

1- Comparative Effectiveness Research, Indirect and Mixed Treatment Comparisons (MTC) : Positioning your innovative technology in the studied therapeutic area;

2- Interactive Health Economics Modeling: Assessing the cost-effectiveness, the cost-utility or the cost-benefit of your innovative health product or technology;

3- Interactive Budget Impact Analysis (IBIA) : Assessing the affordability of your innovative product.

 

 

 

PUBLICATIONS

Scientific Published Papers

Maunoury F, Clément A, Nwankwo C, Levy-Bachelot L, Abergel A, Di Martino V, Thervet E, Durand-Zaleski I. (2018) Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France. PLoS ONE 13(3):e0194329. https://doi.org/10.1371/journal.pone.0194329. 

 

Read more...

FaLang translation system by Faboba

News

New publication: Maunoury F, Clément A, Nwankwo C, Levy-Bachelot L, Abergel A, Di Martino V, Thervet E, Durand-Zaleski I. (2018) Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France. PLoS ONE 13(3):e0194329. https://doi.org/10.1371/journal.pone.0194329.

Statesia took part in an early meeting with the SEESP Department (RP SEESP): MARCH, 2018. Haute Autorité de Santé (HAS), Paris.

Franck Maunoury has carried out a review of two documents written by the Task Force SMDM-ISPOR regarding the concept of "The value of information (VOI)": NOVEMBER, 2017. Paris.

top arrow